The Valley Desk

NCT01498328 · Interventional trial

A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma

Overall registry status Completed

Phase 2

Conditions Giant Cell Glioblastoma, Glioblastoma, Glioblastoma With Oligodendroglial Component, Gliosarcoma, Recurrent Glioblastoma, Relapsed Glioblastoma, Small Cell Glioblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov